APO RESEARCH · REPORT
Subcutaneous Immunoglobulins
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Product & engineering
Understand the product.
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Selected research
Industry Research
Subcutaneous Immunoglobulins Industry Research Report 2026
Market perspective
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
In United States, Subcutaneous Immunoglobulins key players include Shire (Baxalta), Grifols, etc. Global top two manufacturers hold a share over 90%.
South is the largest market, with a share about 35%, followed by West, and Northeast, both have a share about 45 percent.
Read the full market overview
In terms of product, 10% Purity is the largest segment, with a share over 75%. And in terms of application, the largest application is Primary Immunodeficiency, followed by Secondary Immunodeficiency, etc.
Report Scope
This report quantifies the global Subcutaneous Immunoglobulins market in terms of revenue (US$ million) and, where applicable, sales volume (K Bottle), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Bottle) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Subcutaneous Immunoglobulins Market by Company
Shire (Baxalta)
Grifols
CSL
Subcutaneous Immunoglobulins Segment by Purity
0.1
0.2
Subcutaneous Immunoglobulins Segment by Application
Primary Immunodeficiency
Secondary Immunodeficiency
Others
Subcutaneous Immunoglobulins Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Subcutaneous Immunoglobulins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Subcutaneous Immunoglobulins and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Subcutaneous Immunoglobulins.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Subcutaneous Immunoglobulins manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Subcutaneous Immunoglobulins by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Subcutaneous Immunoglobulins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.1
- 0.2
Applications
- Primary Immunodeficiency
- Secondary Immunodeficiency
- Others
Companies covered
- Shire (Baxalta)
- Grifols
- CSL
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Subcutaneous Immunoglobulins Market Size (2021-2032)
- 2.2.2 Global Subcutaneous Immunoglobulins Sales (2021-2032)
- 2.2.3 Global Subcutaneous Immunoglobulins Market Average Price (2021-2032)
- 2.3 Subcutaneous Immunoglobulins by Purity
- 2.3.1 Market Value Comparison by Purity (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.1
- 2.3.3 0.2
- 2.4 Subcutaneous Immunoglobulins by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Primary Immunodeficiency
- 2.4.3 Secondary Immunodeficiency
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Subcutaneous Immunoglobulins Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Subcutaneous Immunoglobulins Sales (K Bottle) of Manufacturers (2021-2026)
- 3.3 Global Subcutaneous Immunoglobulins Revenue of Manufacturers (2021-2026)
- 3.4 Global Subcutaneous Immunoglobulins Average Price by Manufacturers (2021-2026)
- 3.5 Global Subcutaneous Immunoglobulins Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Subcutaneous Immunoglobulins, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Subcutaneous Immunoglobulins, Product Type & Application
- 3.8 Global Manufacturers of Subcutaneous Immunoglobulins, Established Date
- 3.9 Global Subcutaneous Immunoglobulins Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shire (Baxalta)
- 4.1.1 Shire (Baxalta) Company Information
- 4.1.2 Shire (Baxalta) Business Overview
- 4.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shire (Baxalta) Subcutaneous Immunoglobulins Product Portfolio
- 4.1.5 Shire (Baxalta) Recent Developments
- 4.2 Grifols
- 4.2.1 Grifols Company Information
- 4.2.2 Grifols Business Overview
- 4.2.3 Grifols Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Grifols Subcutaneous Immunoglobulins Product Portfolio
- 4.2.5 Grifols Recent Developments
- 4.3 CSL
- 4.3.1 CSL Company Information
- 4.3.2 CSL Business Overview
- 4.3.3 CSL Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 CSL Subcutaneous Immunoglobulins Product Portfolio
- 4.3.5 CSL Recent Developments
5 Global Subcutaneous Immunoglobulins Market Scenario by Region
- 5.1 Global Subcutaneous Immunoglobulins Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Subcutaneous Immunoglobulins Sales by Region: 2021-2032
- 5.2.1 Global Subcutaneous Immunoglobulins Sales by Region: 2021-2026
- 5.2.2 Global Subcutaneous Immunoglobulins Sales by Region: 2027-2032
- 5.3 Global Subcutaneous Immunoglobulins Revenue by Region: 2021-2032
- 5.3.1 Global Subcutaneous Immunoglobulins Revenue by Region: 2021-2026
- 5.3.2 Global Subcutaneous Immunoglobulins Revenue by Region: 2027-2032
- 5.4 North America Subcutaneous Immunoglobulins Market Facts & Figures by Country
- 5.4.1 North America Subcutaneous Immunoglobulins Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Subcutaneous Immunoglobulins Sales by Country (2021-2032)
- 5.4.3 North America Subcutaneous Immunoglobulins Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Subcutaneous Immunoglobulins Market Facts & Figures by Country
- 5.5.1 Europe Subcutaneous Immunoglobulins Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Subcutaneous Immunoglobulins Sales by Country (2021-2032)
- 5.5.3 Europe Subcutaneous Immunoglobulins Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Subcutaneous Immunoglobulins Market Facts & Figures by Country
- 5.6.1 Asia Pacific Subcutaneous Immunoglobulins Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Subcutaneous Immunoglobulins Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Subcutaneous Immunoglobulins Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Subcutaneous Immunoglobulins Market Facts & Figures by Country
- 5.7.1 South America Subcutaneous Immunoglobulins Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Subcutaneous Immunoglobulins Sales by Country (2021-2032)
- 5.7.3 South America Subcutaneous Immunoglobulins Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Subcutaneous Immunoglobulins Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Subcutaneous Immunoglobulins Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Purity
- 6.1 Global Subcutaneous Immunoglobulins Sales by Purity (2021-2032)
- 6.1.1 Global Subcutaneous Immunoglobulins Sales by Purity (2021-2032) & (K Bottle)
- 6.1.2 Global Subcutaneous Immunoglobulins Sales Market Share by Purity (2021-2032)
- 6.2 Global Subcutaneous Immunoglobulins Revenue by Purity (2021-2032)
- 6.2.1 Global Subcutaneous Immunoglobulins Sales by Purity (2021-2032) & (US$ Million)
- 6.2.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Purity (2021-2032)
- 6.3 Global Subcutaneous Immunoglobulins Price by Purity (2021-2032)
7 Segment by Application
- 7.1 Global Subcutaneous Immunoglobulins Sales by Application (2021-2032)
- 7.1.1 Global Subcutaneous Immunoglobulins Sales by Application (2021-2032) & (K Bottle)
- 7.1.2 Global Subcutaneous Immunoglobulins Sales Market Share by Application (2021-2032)
- 7.2 Global Subcutaneous Immunoglobulins Revenue by Application (2021-2032)
- 7.2.1 Global Subcutaneous Immunoglobulins Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Application (2021-2032)
- 7.3 Global Subcutaneous Immunoglobulins Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Subcutaneous Immunoglobulins Value Chain Analysis
- 8.1.1 Subcutaneous Immunoglobulins Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Subcutaneous Immunoglobulins Production Mode & Process
- 8.2 Subcutaneous Immunoglobulins Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Subcutaneous Immunoglobulins Distributors
- 8.2.3 Subcutaneous Immunoglobulins Customers
9 Global Subcutaneous Immunoglobulins Analyzing Market Dynamics
- 9.1 Subcutaneous Immunoglobulins Industry Trends
- 9.2 Subcutaneous Immunoglobulins Industry Drivers
- 9.3 Subcutaneous Immunoglobulins Industry Opportunities and Challenges
- 9.4 Subcutaneous Immunoglobulins Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst